Safety and Efficacy of FT218 in Idiopathic Hypersomnia (REVITALYZ)
NCT06525077
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
157
Enrollment
INDUSTRY
Sponsor class
Conditions
Idiopathic Hypersomnia
Interventions
DRUG:
FT218
OTHER:
Placebo
Sponsor
Avadel